Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chana L. Glasser"'
Autor:
Chana L. Glasser, Jing Chen
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 1886 (2023)
Treatment for relapsed acute lymphoblastic leukemia (ALL) in children and young adults continues to evolve. Despite optimization of cytotoxic chemotherapeutic approaches and risk-adapted therapy, about 12% of pediatric patients still relapse, and sur
Externí odkaz:
https://doaj.org/article/97605c3d1e524d7fbb84278ddfa6312e
Autor:
Jing Chen, Chana L. Glasser
Publikováno v:
Children, Vol 7, Iss 2, p 12 (2020)
The relapse rate for children with acute myeloid leukemia (AML) remains high despite advancements in risk classification, multi-agent chemotherapy intensification, stem cell transplantation, and supportive care guidelines. Prognosis for this subgroup
Externí odkaz:
https://doaj.org/article/8c30a3f663f24b309379a3daa91bd039
Autor:
Chana L. Glasser, MD
Publikováno v:
Leukemia Research Reports, Vol 8, Iss C, Pp 19-20 (2017)
Tumor Lysis Syndrome (TLS) is a well-known complication of induction therapy for hematologic malignancies. It is characterized by rapid breakdown of malignant white blood cells (WBCs) leading to metabolic derangements and serious morbidity if left un
Externí odkaz:
https://doaj.org/article/0e32eb815f3348b8af0470c2243095d3
Autor:
Danielle M. Wolfe, Andrea Webster Carrion, Mahesh M. Masukhani, Jennifer A. Oberg, Jovana Pavisic, Alexander El-Ali, Mala Gupta, Katherine Weng, Chana L. Glasser
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e525-e529
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d29330fc6281b6b836b19da7c4384e7
https://doi.org/10.1097/mph.0000000000002593
https://doi.org/10.1097/mph.0000000000002593
Autor:
Alexandra M. Stevens, Terzah M. Horton, Chana L. Glasser, Robert B. Gerbing, Richard Aplenc, Todd A. Alonzo, Michele S. Redell
Publikováno v:
Pediatric hematology and oncology.
Pediatric acute myeloid leukemia (AML) is a devastating disease with a high risk of relapse. Current risk classification designates patients as high or low risk (LR) based on molecular features and therapy response. However, 30% of LR patients still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ce8b5402ac6bc30a13afc17fd865a9
https://pubmed.ncbi.nlm.nih.gov/35838057
https://pubmed.ncbi.nlm.nih.gov/35838057
Publikováno v:
Pediatric Hematology and Oncology. 38:444-455
Respiratory viral infections (RVIs) affect children year-round, with seasonal-specific patterns. Pediatric oncology patients are uniquely vulnerable to infection, but whether this predisposes them to different patterns of RVIs than healthy children i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4b7f3ad5b349d0c4ff053130ae8726
https://doi.org/10.1080/08880018.2020.1871137
https://doi.org/10.1080/08880018.2020.1871137
Publikováno v:
Infectious Diseases in Clinical Practice (Baltimore, Md.)
Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 may present with fever, elevated inflammatory markers, and multiorgan involvement. Although the gastrointestinal system is commonly affected in MIS-C patients, associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae03b9649142361a30c8e4c1f56b32a
https://doi.org/10.1097/ipc.0000000000001013
https://doi.org/10.1097/ipc.0000000000001013
Publikováno v:
Pediatric hematology and oncology. 38(8)
Infections are responsible for most treatment-related morbidity and mortality in pediatric acute myeloid leukemia (AML). Children's Oncology Group (COG) recommends hospitalization following chemotherapy until early absolute neutrophil count (ANC) rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88eca63f8268adff46b885499c907cd8
https://pubmed.ncbi.nlm.nih.gov/33792501
https://pubmed.ncbi.nlm.nih.gov/33792501
Autor:
Prakash Satwani, Joanna Pierro, Shari Feinberg, Teena Bhatla, Elizabeth A. Raetz, Burton Appel, Prachi Kothari, Kenan Onel, Archana Sharma, Laura Hogan, Ashley Pinchinat, William L. Carroll, Adam S. Levy, P. Pallavi Madhusoodhan, Adit Tal, Bradley Gampel, Jordan Musante, Alissa Kahn, Chana L. Glasser
Publikováno v:
Pediatric Blood & Cancer
Purpose Pediatric oncology patients undergoing active chemotherapy are suspected to be at a high risk for severe disease secondary to severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection; however, data to support this are lack
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ab78578535af4a3c6695665fc8b0fb6
http://europepmc.org/articles/PMC7883045
http://europepmc.org/articles/PMC7883045
Autor:
Chana L. Glasser, Sylwia Jasinski
Publikováno v:
Journal of Pediatric Hematology/Oncology. 41:624-626
While packed red blood cell (PRBC) transfusion therapy is a mainstay in the treatment of certain patients with sickle cell disease (SCD) and the standard of care for preoperative management, there are associated risks. Delayed hemolytic transfusion r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672e5bd0f817450560ccee87a382032e
https://doi.org/10.1097/mph.0000000000001307
https://doi.org/10.1097/mph.0000000000001307